Malignant tumors in tuberous sclerosis complex: a case report and review of the literature

Cassie Liu,Subodh M. Lele,Martin H. Goodenberger,Gwendolyn M. Reiser,Andrew J. Christiansen,James C. Padussis
DOI: https://doi.org/10.1186/s12920-024-01913-8
2024-05-28
BMC Medical Genomics
Abstract:Tuberous sclerosis complex (TSC) is a rare, autosomal dominant genetic disease that arises from TSC1 or TSC2 genetic mutations. These genetic mutations can induce the development of benign tumors in any organ system with significant clinical implications in morbidity and mortality. In rare instances, patients with TSC can have malignant tumors, including renal cell carcinoma (RCC) and pancreatic neuroendocrine tumor (PNET). It is considered a hereditary renal cancer syndrome despite the low incidence of RCC in TSC patients. TSC is typically diagnosed in prenatal and pediatric patients and frequently associated with neurocognitive disorders and seizures, which are often experienced early in life. However, penetrance and expressivity of TSC mutations are highly variable. Herein, we present a case report, with associated literature, to highlight that there exist undiagnosed adult patients with less penetrant features, whose clinical presentation may contain non-classical signs and symptoms, who have pathogenic TSC mutations.
genetics & heredity
What problem does this paper attempt to address?